Company intelligence / Profile preview
Ximeien
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
Overview
Ximeien is a specialized biotechnology company based in Shanghai, China, focused on the intersection of synthetic biology and regenerative medicine. The company specializes in the development and large-scale production of engineered exosomes and recombinant humanized proteins, primarily for dermatology and medical aesthetic applications. Ximeien's proprietary platform enables the standardized extraction and purification of bioactive substances, including growth factors and collagen variants, which are used to promote tissue repair and skin regeneration. While the company provides ingredients to the clinical aesthetics market, it is also advancing a research pipeline aimed at therapeutic exosome-based delivery systems and wound healing treatments. Ximeien maintains integrated R&D and manufacturing facilities to support its synthetic biology initiatives.
- Therapeutic areas
- Dermatology
- Modalities
- Exosome-based therapyRecombinant proteinPeptides
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Ximeien.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ximeien.